MR spectroscopy glutamate measures reflect craving for heroin in addicts

Article

New MR spectroscopy findings indicate that changes in brain glutamate levels reflect changes in heroin craving among addicts during methadone maintenance therapy. MRS may eventually help predict whether addicts will relapse after treatment.

New MR spectroscopy findings indicate that changes in brain glutamate levels reflect changes in heroin craving among addicts during methadone maintenance therapy. MRS may eventually help predict whether addicts will relapse after treatment.

Animal studies have previously shown that glutamate is involved in the development and expression of drug addiction. Drug exposure and withdrawal change the glutamate levels in the anterior cingulate cortex, ventral striatum, thalamus, and hippocampus.

Dr. Mark Greenwald and colleagues at Wayne State University established for the first time that glutamate changes can be measured in humans. Their data demonstrate a significant correlation between glutamate levels and heroin craving during methadone detoxification therapy.

Six heroin addicts aged 31 to 55 years and healthy age-matched controls participated in the study.

Baseline H-1 MR spectroscopic scans were completed several days after the start ofa methadone treatment regimen. Follow-up MRS evaluations were performed about one month after the baseline scan.All patients showed significantly lower glutamate levels in the anterior cingulate while they received the high methadone dosage than during lower dose administrations (p

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.